SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-044597
Filing Date
2023-12-12
Accepted
2023-12-12 17:17:03
Documents
17
Period of Report
2023-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 72204
2 ex2-1.htm EX-2.1 749739
3 ex3-1.htm EX-3.1 339515
4 ex99-1.htm EX-99.1 46807
5 ex99-1_001.jpg GRAPHIC 2226
6 ex99-1_002.jpg GRAPHIC 3287
  Complete submission text file 0001493152-23-044597.txt   1616693

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE evfm-20231211.xsd EX-101.SCH 3009
8 XBRL LABEL FILE evfm-20231211_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE evfm-20231211_pre.xml EX-101.PRE 22355
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3336
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 231482080
SIC: 2834 Pharmaceutical Preparations